CapsoVision executive exercises 107,357 stock options

Q: How did the CapsoVision (CV) reverse stock split affect the reported Form 4 data?

Footnotes explain that both the exercise prices and number of shares reported give effect to a 1-for-3.33 reverse stock split. This split occurred on July 2, 2025 in connection with CapsoVision’s initial public offering, adjusting outstanding options accordingly.

CapsoVision, Inc Head of Global Sales Douglas Patrick Atkinson exercised stock options to acquire a total of 107,357 shares of common stock on May 4–5, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

CapsoVision, Inc Head of Global Sales Douglas Patrick Atkinson exercised stock options to acquire a total of 107,357 shares of common stock on May 4–5, 2026. The options were exercised at prices of $0.2863, $0.3663 and $0.5661 per share, with the exercise prices and share counts reflecting a 1‑for‑3.33 reverse stock split completed in connection with the company’s initial public offering. Following these exercises, he directly holds 107,357 common shares and retains 18,769 stock options with a $0.5661 exercise price expiring on July 23, 2033. No open‑market sales were reported in this filing.

Insider Trade Summary

107,357 shares exercised/converted

Exercise 8 txns

Insider Atkinson Douglas Patrick

Role Head of Global Sales

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	34,786	$0.00	$0.00
Exercise	Common Stock	34,786	$0.5661	$20K
Exercise	Stock Option (right to buy)	36,036	$0.00	$0.00
Exercise	Stock Option (right to buy)	30,030	$0.00	$0.00
Exercise	Stock Option (right to buy)	6,505	$0.00	$0.00
Exercise	Common Stock	36,036	$0.2863	$10K
Exercise	Common Stock	30,030	$0.3663	$11K
Exercise	Common Stock	6,505	$0.5661	$4K

Holdings After Transaction: Stock Option (right to buy) — 18,769 contracts (Direct); Common Stock — 107,357 shares (Direct)

Footnotes (4)

F1. The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering.
F2. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering.
F3. The option is fully vested and exercisable as of the transaction date.
F4. The option is partially vested and exercisable as of the transaction date.

Key Figures

Options Exercised: 107,357 shares Post-transaction holdings: 107,357 shares Exercise price 1: $0.2863/share +5 more

8 metrics

Options Exercised 107,357 shares Total common shares acquired via option exercises on May 4–5, 2026

Post-transaction holdings 107,357 shares Common stock directly held after the reported transactions

Exercise price 1 $0.2863/share One tranche of stock options exercised into common stock

Exercise price 2 $0.3663/share Second tranche of stock options exercised into common stock

Exercise price 3 $0.5661/share Third tranche of stock options exercised into common stock

Remaining options 18,769 options Stock options outstanding at $0.5661 exercise price after exercises

Option expiration (2033) July 23, 2033 Expiration date for remaining $0.5661 stock options

Option expiration (2031) June 14, 2031 Expiration date for one exercised option grant at $0.3663

Key Terms

Stock Option (right to buy), reverse stock split, initial public offering, exercise price

4 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

reverse stock split financial

"gives effect to a 1-for-3.33 reverse stock split"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

initial public offering financial

"reverse stock split effected ... in connection with its initial public offering"

An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

exercise price financial

"The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CapsoVision (CV) report for Douglas Patrick Atkinson?

CapsoVision reported that Head of Global Sales Douglas Patrick Atkinson exercised stock options to acquire 107,357 shares of common stock. These exercises occurred on May 4–5, 2026 and did not include any open-market sales in this filing.

At what prices were the CapsoVision (CV) stock options exercised in this Form 4?

Douglas Patrick Atkinson exercised CapsoVision stock options at exercise prices of $0.2863, $0.3663, and $0.5661 per share. The footnotes state these prices reflect a 1-for-3.33 reverse stock split completed in connection with CapsoVision’s initial public offering.

How many CapsoVision (CV) shares does Douglas Patrick Atkinson hold after the reported transactions?

After the reported option exercises, Douglas Patrick Atkinson directly holds 107,357 shares of CapsoVision common stock. This total reflects the new shares acquired through exercises on May 4–5, 2026, as shown in the post-transaction ownership fields.

Does the CapsoVision (CV) Form 4 show any remaining stock options for Douglas Patrick Atkinson?

Yes. After exercising multiple tranches, Douglas Patrick Atkinson still holds 18,769 stock options with a $0.5661 exercise price. These remaining options are scheduled to expire on July 23, 2033, according to the derivative transaction details.

Were any CapsoVision (CV) shares sold in the insider transactions reported here?

No sales are reported in this Form 4. All transactions coded “M” reflect option exercises, where options were converted into shares of CapsoVision common stock. The summary data show no open-market purchases or sales and a net neutral buy/sell direction.

How did the CapsoVision (CV) reverse stock split affect the reported Form 4 data?

Footnotes explain that both the exercise prices and number of shares reported give effect to a 1-for-3.33 reverse stock split. This split occurred on July 2, 2025 in connection with CapsoVision’s initial public offering, adjusting outstanding options accordingly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/06/2026 - 12:50 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Atkinson Douglas Patrick

(Last)

(First)

(Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA

CALIFORNIA

95070

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Head of Global Sales

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/04/2026		M		36,036	A	$0.2863⁽¹⁾	36,036⁽²⁾	D
Common Stock	05/04/2026		M		30,030	A	$0.3663⁽¹⁾	66,066⁽²⁾	D
Common Stock	05/04/2026		M		6,505	A	$0.5661⁽¹⁾	72,571⁽²⁾	D
Common Stock	05/05/2026		M		34,786	A	$0.5661⁽¹⁾	107,357⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$0.2863⁽¹⁾	05/04/2026		M			36,036	⁽³⁾	11/09/2026	Common Stock	36,036⁽²⁾	$0	0	D
Stock Option (right to buy)	$0.3663⁽¹⁾	05/04/2026		M			30,030	⁽³⁾	06/14/2031	Common Stock	30,030⁽²⁾	$0	0	D
Stock Option (right to buy)	$0.5661⁽¹⁾	05/04/2026		M			6,505	⁽⁴⁾	07/23/2033	Common Stock	6,505⁽²⁾	$0	53,555⁽²⁾	D
Stock Option (right to buy)	$0.5661⁽¹⁾	05/05/2026		M			34,786	⁽⁴⁾	07/23/2033	Common Stock	34,786⁽²⁾	$0	18,769⁽²⁾	D

Explanation of Responses:

1. The exercise price reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering.

2. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split effected by the Issuer on July 2, 2025 in connection with its initial public offering.

3. The option is fully vested and exercisable as of the transaction date.

4. The option is partially vested and exercisable as of the transaction date.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Douglas Atkinson	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR